申请人:Merck & Co., Inc.
公开号:US05869496A1
公开(公告)日:1999-02-09
Disclosed are spiro-substituted azacycles of formula (I), are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, emesis and asthma. In particular compounds of formula (I) are shown to be neurokinin antagonists. ##STR1##
公开了公式(I)的螺环取代氮杂环,是治疗炎症性疾病、疼痛或偏头痛、呕吐和哮喘的缓激肽受体拮抗剂。特别地,公式(I)的化合物被证明是神经激肽拮抗剂。